Aurora Cannabis (ACB) Total Current Liabilities (2018 - 2026)
Aurora Cannabis (ACB) posted quarterly Total Current Liabilities of $48.8 million for Q1 2026, down 36.83% year-on-year from $77.3 million in Q1 2025, and down 36.83% on a QoQ basis from $77.3 million in Q1 2025.
Aurora Cannabis (ACB) Total Current Liabilities (2018 - 2026) Analysis & Trends
Aurora Cannabis (ACB) has reported Total Current Liabilities for 9 consecutive years, with $48.8 million the latest figure, recorded in Q1 2026.
- Quarterly Total Current Liabilities fell 36.83% year-over-year to $48.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $48.8 million (down 36.83% YoY) and the FY2026 annual result came in at $48.4 million, down 39.27% from the prior year.
- Total Current Liabilities declined to $48.8 million in Q1 2026 per ACB's latest filing, from $77.3 million in the prior quarter.
- Over the last five years, Total Current Liabilities for ACB reached as high as $175.9 million in Q1 2023 and fell as low as $48.8 million in Q1 2026.
- A 5-year average of $99.4 million and a median of $92.5 million in 2024 frame the typical range for Total Current Liabilities.
- Annual changes were most pronounced in 2022 — Total Current Liabilities grew 8.41% — and 2024, when it slumped 47.41%.
- Year by year, Total Current Liabilities stood at $102.6 million in 2022, then jumped by 71.34% to $175.9 million in 2023, then sank by 47.41% to $92.5 million in 2024, then dropped by 16.46% to $77.3 million in 2025, then tumbled by 36.83% to $48.8 million in 2026.
- According to Business Quant data, Total Current Liabilities over the past three periods registered $48.8 million, $77.3 million, and $92.5 million for Q1 2026, Q1 2025, and Q1 2024 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 6.56 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 13.53 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 2.05 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 18.06 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 599.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 13.17 Bn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 6.81 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 831.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 1.66 Bn |
| 10 | Aurora Cannabis | 1.11 Bn | 1.03 Bn | 21.72 Mn | 48.81 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 48.81 Mn |
| Mar 31, 2025 | 77.26 Mn |
| Mar 31, 2024 | 92.48 Mn |
| Mar 31, 2023 | 175.85 Mn |
| Jun 30, 2022 | 102.64 Mn |
| Jun 30, 2021 | 94.67 Mn |
| Jun 30, 2020 | 196.35 Mn |
| Jun 30, 2019 | 326.14 Mn |
| Jun 30, 2018 | 58.26 Mn |